The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Your mother and father will not get the compassion and care when they call for medical help . It will not be available. Your family physician was financially forced to leave.
Pain is a complex of the personal, subjective, and unpleasant experiences that may or may not be related to physical injury or tissue damage. It has been described “timeless, ineluctable, and disconcertingly indefinable.” The expression may be influenced by psychosocial, ...
Lundbeck has now disclosed the mechanism of action of its “mixed serotonin modulator and stimulator,” albeit buried in a first quarter report. Data on LuAA21004, Lundbeck’s lead antidepressant jointly in development with Takeda, was released at the Scandinavian College of Neuro-Psychopharmacology...
Taro just got approval for Rx cetirizine - big whoop! Zyrtec has been OTC in all forms (tablet, chewable and syrup) since 11/07. Do you know anyone who will write a prescription for an OTC drug or an insurance company that will cover it?
We need to look to the cause of why we prescribe antipsychotics to patients with dementia. We have very few tools to use and sometimes these drugs are a necessity.
Glaxo has just gotten approval for Kinrix (DTaP-IPV). It's products for infants and toddlers, Pediarix (DTaP-HepB-IPV) and Infanrix (DTaP) are used in children under 2; Kinrix will be used for the 4-6 year booster dose, reducing by 1 the number of vacthat children get at this age.
This article clearly describes the Catch-22 in which most doctors, except for those employed by the large institutions, find themselves. We cannot afford to practice the "best" medicine, and yet, if we could, we might well make fewer errors and make medical care for our patients more seamless. ...
The FDA is opening investigations into whether the widely used plastic additive bisphenol A may have various effects on humans, based on animal models. Several companies are already touting their "BPA-free" status; as the FDA investigation will take a prolonged period to review and summarize available...
-Datascope has decided to exit the monitor market by selling a chunk of itself off, possibly making itself into a takeover candidate. The remaining units make stents, balloon catheters and other cardiac equipment. -One other effect is that it has placed itself into direct (rather than indirect)...
-Novartis' press conference discussed a "full pipline" of new vaccines, but the majority are still Phase I. -The meningitis vaccines being developed are not yet ready to go, and the one that is closest to being filed already has a competitor on the market.